CD274 and neoplasm: If suppression of the anti-tumor activity of PD-L1 on iNOS+TILs occurs, anti-PD-L1 therapies may be more effective in NSCLCs with PD-L1+/high iNOS+TIL score tumors compared to PD-L1+ cold tumors.